Good news from medical research
Jan. 28th, 2017 10:14 pm![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
[Content notes: HIV, needles, animal experiments.]
Ars Technica: new antibody suppresses spread of HIV-1 in infected individuals. The Nature Medicine: this appears to prevent infection of (some subtypes of) HIV-1 in humanised mice and macaques. Lots of potential for combination therapies -- and one subject (not using antiretroviral therapies) maintained viral suppression for over eight weeks post-infusion with this antibody (note that the antibody's halflife is 12.8 days in individuals infected with HIV-1).
(I didn't know about subtypes of HIV, but now I do! ; AVERT.)
Ars Technica: new antibody suppresses spread of HIV-1 in infected individuals. The Nature Medicine: this appears to prevent infection of (some subtypes of) HIV-1 in humanised mice and macaques. Lots of potential for combination therapies -- and one subject (not using antiretroviral therapies) maintained viral suppression for over eight weeks post-infusion with this antibody (note that the antibody's halflife is 12.8 days in individuals infected with HIV-1).
(I didn't know about subtypes of HIV, but now I do! ; AVERT.)
(no subject)
Date: 2017-01-28 11:12 pm (UTC)(no subject)
Date: 2017-01-29 01:52 pm (UTC)(no subject)
Date: 2017-01-30 04:46 pm (UTC)